- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Advances in Urology
Volume 2014 (2014), Article ID 627290, 4 pages
Incidental Prostate Cancer in Transurethral Resection of the Prostate Specimens in the Modern Era
1Department of Urology, Weill Medical College of Cornell University, New York-Presbyterian Hospital, 425 E 61st Street, New York, NY 10065, USA
2Department of Pathology & Laboratory Medicine, Weill Medical College of Cornell University, New York-Presbyterian Hospital, New York, NY 10065, USA
Received 21 January 2014; Accepted 12 April 2014; Published 29 April 2014
Academic Editor: Matthew Nielsen
Copyright © 2014 Brandon Otto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- B. Tombal, L. de Visccher, J. P. Cosyns et al., “Assessing the risk of unsuspected prostate cancer in patients with benign prostatic hypertrophy: a 13-year retrospective study of the incidence and natural history of T1a-T1b prostate cancers,” BJU International, vol. 84, no. 9, pp. 1015–1020, 1999.
- J. E. Fowler Jr., P. Pandey, S. A. Bigler, D. T. Yee, and J. M. Kolski, “Trends in diagnosis of stage T1a-b prostate cancer,” Journal of Urology, vol. 158, no. 5, pp. 1849–1852, 1997.
- X. Yu, S. P. Elliott, T. J. Wilt, and A. M. McBean, “Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies,” Journal of Urology, vol. 180, no. 1, pp. 241–245, 2008.
- S. Voigt, F. Hüttig, R. Koch et al., “Risk factors for incidental prostate cancerwho should not undergo vaporization of the prostate for benign prostate hyperplasia?” Prostate, vol. 71, no. 12, pp. 1325–1331, 2011.
- J. R. Srigley, P. A. Humphrey, M. B. Amin et al., “Protocol for the examination of specimens from patients with carcinoma of the prostate gland,” Archives of Pathology and Laboratory Medicine, vol. 133, no. 10, pp. 1568–1576, 2009.
- K. T. Mai, P. A. Isotalo, J. Green, D. G. Perkins, C. Morash, and J. P. Collins, “Incidental prostatic adenocarcinomas and putative premalignant lesions in TURP specimens collected before and after the introduction of prostrate-specific antigen screening,” Archives of Pathology and Laboratory Medicine, vol. 124, no. 10, pp. 1454–1456, 2000.
- J. S. Jones, H. W. Follis, and J. R. Johnson, “Probability of finding T1a and T1b (Incidental) prostate cancer during TURP has decreased in the PSA era,” Prostate Cancer and Prostatic Diseases, vol. 12, no. 1, pp. 57–60, 2009.
- T. Dellavedova, R. Ponzano, L. Racca, F. Minuzzi, and M. Dominguez, “Prostate cancer as incidental finding in transurethral resection,” Archivos Espanoles de Urologia, vol. 63, no. 10, pp. 855–861, 2010.
- B. T. Helfand, C. B. Anderson, A. Fought, D. Y. Kim, A. Vyas, and K. T. McVary, “Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia,” Urology, vol. 74, no. 1, pp. 177–183, 2009.
- K. Trpkov, J. Thompson, A. Kulaga, and A. Yilmaz, “How much tissue sampling is required when unsuspected minimal prostate carcinoma is identified on transurethral resection?” Archives of Pathology and Laboratory Medicine, vol. 132, no. 8, pp. 1313–1316, 2008.
- C. Yoo, C. Oh, S. Kim, et al., “Preoperative clinical factors for diagnosis of incidental prostate cancer in the era of tissue-ablative surgery for benign prostatic hyperplasia: a korean multi-center review,” Korean Journal of Urology, vol. 53, no. 6, pp. 391–395, 2012.
- J. I. Epstein, G. Paull, J. C. Eggleston, and P. C. Walsh, “Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup,” Journal of Urology, vol. 136, no. 4, pp. 837–839, 1986.
- A. Descazeaud, M. Peyromaure, A. Salin et al., “Predictive factors for progression in patients with clinical stage T1a prostate cancer in the PSA era,” European Urology, vol. 53, no. 2, pp. 355–361, 2008.
- L. Lee, S. Thiruneelakandasivam, M. Hong et al., “Are transrectal prostate biopsies routinely indicated in patients with incidentally diagnosed prostate cancer following transurethral resection of the prostate for benign disease?” Urologia Internationals, vol. 91, no. 4, pp. 397–403, 2013.
- U. Capitanio, V. Scattoni, M. Freschi et al., “Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence,” European Urology, vol. 54, no. 1, pp. 118–125, 2008.
- A. Magheli, S. Rais-Bahrami, H. B. Carter, H. J. Peck, J. I. Epstein, and M. L. Gonzalgo, “Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy,” Journal of Urology, vol. 178, no. 4, pp. 1277–1281, 2007.
- B. T. Helfand, A. K. Mongiu, D. Kan et al., “Outcomes of radical prostatectomy for patients with clinical stage T1a and T1b disease,” BJU International, vol. 104, no. 3, pp. 304–309, 2009.